MRVI

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a specialized life sciences company that provides critical reagents and testing services to support the development of modern biotechnology therapies. Founded in 2020 through the combination of several established life sciences businesses, the company went public in November 2020 during the height of the COVID-19 pandemic. Maravai operates as a key supplier to the biotechnology and pharmaceutical industries, offering essential components for mRNA therapeutics, gene therapies, and biologic drug development. The company is headquartered in San Diego, California, and has experienced significant volatility as it transitions from pandemic-era revenues to a more diversified business model focused on emerging therapeutic modalities.